Seminar & Colloquium
[세미나: 11월 20일(수), 오전 9시] Prof. Giovanni Traverso, Department of Mechanical Engineering, Massachusetts Institute of Technology
Title
Ingestible Therapeutics
Speaker
Prof. Giovanni Traverso, Associate Professor, Department of Mechanical Engineering, Massachusetts Institute of Technology, Division of Gastroenterology, Brigham and Women’s Hospital, Harvard Medical School
* Biography
Dr. Traverso is an Associate Professor in the Department of Mechanical Engineering at the Massachusetts Institute of Technology and in the Division of Gastroenterology, Brigham and Women’s Hospital (BWH), Harvard Medical School. Dr. Traverso grew up in Peru, Canada and the United Kingdom. He received his BA from Trinity College, University of Cambridge, UK, and his PhD from the lab of Prof. Bert Vogelstein at Johns Hopkins University. He subsequently completed medical school at the University of Cambridge, internal medicine residency at the Brigham and Women’s Hospital and his gastroenterology fellowship training at Massachusetts General Hospital, both at Harvard Medical School. Dr. Traverso’s previous work focused on the development of novel molecular tests for the early detection of colon cancer which was published in the New England Journal of Medicine and The Lancet. This work was licensed to Exact Sciences and led to the development of the FDA-approved non-invasive test Cologuard for colon cancer screening. For his post-doctoral research, he worked in the laboratory of Professor Robert Langer at the Massachusetts Institute of Technology (MIT) where he developed a series of novel technologies for drug delivery as well as physiological sensing via the gastrointestinal tract.
Dr. Traverso’s contributions have been recognized through several awards including, the Grand Prize of the Collegiate Inventors Competition, a Research Fellowship from Trinity College (Cambridge, UK), being recognized on the MIT Tech Review’s TR 35 list and the 2023 Acta Biomaterials Silver Medal. Additionally, Dr. Traverso has been elected to the American Society for Clinical Investigation, the National Academy (NAM) Emerging Leaders in Health and Medicine Scholars program, the College of Fellows of the Controlled Release Society, the American Institute of Medical and Biological Engineering and the National Academy of Inventors.
His current research program is focused on developing the next generation of drug delivery systems to enable efficient delivery of therapeutics through the gastrointestinal tract as well developing novel ingestible electronic devices for sensing a broad array of physiologic and pathophysiologic parameters.
| Date | Wednesday, November 20th, 2024
| Time | 09:00 ~ 11:00
| Venue | 온라인 줌 (https://snu-ac-kr.zoom.us/j/81257096676?pwd=ASIGklef5S84L7LJIaCZrIjIw1CQ1c.1)
ID: 812 5709 6676
Password: 1010
[Abstract]
Prof. Traverso will aim to review ongoing efforts in his lab towards the development of ingestible therapeutic and sensing technologies capable of operating in extreme environments like the gastrointestinal tract. Specifically, he will present advances in materials science, device development and translational efforts towards addressing medication non-adherence, the dosing of macromolecules and electroceuticals.
| Host | 강승균 교수(02-880-5756)